-
Heavy! The eighth batch of centralized procurement is about to start reporting (with a list
Time of Update: 2023-02-01
The belated eighth batch of collective procurement has officially begun. After today's collective procurement symposium, the corresponding variety catalog has flowed out. According to online documents
-
(Avounibu Tablets) China Listing Conference · East China & Central China Station was successfully held
Time of Update: 2023-01-07
The golden qi is at the autumn equinox, and the rain in the gorge falls. CStone Pharmaceuticals' world's first IDH1 inhibitor, Tosuvo ® (ivoranib tablets), has entered clinical application in China, f
-
Zhejiang Province Centralized Drug Procurement Results Announced (with List)
Time of Update: 2022-12-30
The data shows that the total sales scale of this collection and procurement varieties in public hospitals in Zhejiang Province in 2021 exceeded 300 million yuan (in terms of common names), involving bright prorelin injection, triptorelin injection, lactulose oral liquid and other large clinical varieties, Lizhu, Shisi Yao, Luoxin Pharmaceutical and other enterprises successfully broke through.
-
The SASAC has announced a list of counterfeit central enterprises! Including 6 oil-related companies
Time of Update: 2022-10-01
Recently, some central enterprises have announced a number of fake state-owned enterprises list, making it clear that the relevant companies and their subsidiaries at all levels are counterfeit state-
-
Centralized procurement of proprietary Chinese medicines: All these large varieties are reduced in price (list attached)
Time of Update: 2022-02-23
Industry insiders believe that the centralized procurement of Chinese patent medicines in 19 provinces in Hubei this time is carried out by pharmaceutical companies that independently fill in information such as enterprise and product information, benchmark prices, and technical evaluation indicators, resulting in the centralized procurement price limit of each variety being "one price for one factory", thus.
-
The National Medical Insurance Administration issued a list of public service items for centralized procurement of medicines and medical consumables
Time of Update: 2021-09-13
Attachment: List of public service items for centralized procurement of medicines and medical consumables National Medical Security Administration Medical Price and Bidding Procurement Guidance Center August 25, 2021 Medical Network, August 31.
-
North China Pharmaceutical's "National Centralized Procurement Out of Stock" was included in the "List of Violations"
Time of Update: 2021-09-04
(hereinafter referred to as "Huabei Pharmaceutical"), the selected company in the third batch of nationally organized drug centralized procurement of ibuprofen sustained-release capsules, failed to supply the agreed procurement volume in Shandong Province according to the agreement.
-
The fifth round of centralized drug procurement, 79 varieties or selected (list attached)
Time of Update: 2021-07-15
According to Cyber Blue, the 79 varieties that meet the requirements of national procurement so far involve a number of multinational pharmaceutical companies-including Bayer, AstraZeneca, Takeda, GlaxoSmithKline, Xinji, Roche, Sanofi, Li Lai, Daiichi Sankyo, Boehringer Ingelheim, Pfizer, Novartis, General Electric, Braun, Otsuka Pharmaceutical, Gilead, Xi'an Janssen, Merck, Fresenius Kabi, Squibb, Tanabe Mitsubishi Pharmaceuticals, Saisheng Waiting for more than 20 houses .
-
The Central Ecological and Environmental Protection Inspector's first list of central enterprises' problems revealed that ChemChina was punished 287 times
Time of Update: 2021-06-11
On May 12, the seventh and eighth central ecological and environmental protection inspection teams of the central government disclosed their inspections of the two state-owned enterprises of China National Chemical Industry and China Minmetals Corporation.
-
Centralized procurement pressures listed pharmaceutical companies to sell subsidiaries!
Time of Update: 2021-05-22
Recently, A-share listed company Nanjing Hi-Tech announced that it will publicly transfer its holding subsidiary Nanjing Chengong Pharmaceutical Co.
Finally, in January and February this year, Laimei Pharmaceuticals disposed of the assets of these four subsidiaries by means of transfer and contracting operations.
-
Notice on launching the supply list of selected varieties in the fourth batch of nationally
Time of Update: 2021-04-24
All relevant units: In accordance with the implementation of the fourth batch of national organization drug centralized procurement and use related requirements in this city, the relevant selected product supply list and the confirmation of the distributor will be carried out in the near future.
-
8 major varieties, the implementation of centralized procurement results (list attached)
Time of Update: 2021-04-19
Centralized procurement expansion and contract renewal, competition between pharmaceutical companies continues The first round of 4+7 centralized procurement: 11 pilot cities, 25 varieties, a 12-month procurement cycle, the centralized procurement document was released on November 15, 2018, and the official results were released on December 7, 2018, and 2-3 in 2019 It will land in the next month, that is to say, by February-February 2020, the results of the first round of centralized procurement will be basically implemented.
-
Qiao Jie, Zhang Liyang on the list! The list of advanced individual recommendations for the central
Time of Update: 2020-08-20
Regarding the publicity of the central and state organs to combat the outbreak of new crown pneumonia, the public ity of the official recommendation object of the national recognition and recommendati
-
Injection enters a new round of centralized procurement list, 2020 consistency evaluation tug-of-war begins
Time of Update: 2020-01-03
Years and weeks turn around 2020 has quietly arrived The past 2019 is the year of policy implementation Volume purchase, negotiation and access of the new version of medical insurance catalog, and the
-
Injection enters a new round of centralized procurement list, 2020 consistency evaluation tug-of-war begins
Time of Update: 2020-01-02
Original: Shisheng Years and weeks turn around 2020 has quietly arrived The past 2019 is the year of policy implementation Volume purchase, negotiation and access of the new version of medical insuran
